Buprenorphine

15 registered clinical trials studyying Buprenorphine — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder NCT07158853	University of Minnesota	N/A
Not Yet Recruiting	Injectable Buprenorphine in Prison: a Preference Trial NCT06880718	Lifespan	Phase 4
Active Not Recruiting	Comparative Efficacy of Buprenorphine Transdermal Patch Versus Tramadol in Postoperative Analgesia for Shoulde NCT06742554	medina medical center	Phase 4
Terminated	Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 NCT04480554	University of Pennsylvania	Phase 2
Active Not Recruiting	Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing NCT05505227	Ohio University	N/A
Completed	Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion NCT04254081	University of California, San Diego	Phase 4
Completed	Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD NCT03658642	Yale University	N/A
Active Not Recruiting	Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior NCT03221309	University of Maryland, Baltimore	—
Completed	Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis NCT03048643	Laura Fanucchi	N/A
Terminated	The Effects of Opioid Taper on Opioid-Induced Hyperalgesia NCT03063905	Georgetown University	—
Completed	Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair NCT03380533	Hospital Italiano de Buenos Aires	Phase 2 / Phase 3
Completed	Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users NCT01108679	Albert Einstein College of Medicine	—
Completed	Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in NCT00723697	Indivior Inc.	—
Completed	Integrating Buprenorphine Into the SFGH AIDS Program NCT00263458	University of California, San Francisco	Phase 4
Completed	Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) NCT00798538	Yale University	Phase 4